Hara Capital’s AstraZeneca AZN Stock Holding History

Hara Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.79K	Hold	20	–	–	﹤0.01%	271
2026 Q1	$3.94K	Hold	20	–	–	﹤0.01%	283
2025 Q4	$3.68K	Hold	20	–	–	﹤0.01%	271
2025 Q3	$3.07K	Hold	20	–	–	﹤0.01%	271
2025 Q2	$2.79K	Hold	20	–	–	﹤0.01%	301
2025 Q1	$2.94K	Hold	20	–	–	﹤0.01%	265
2024 Q4	$2.62K	Hold	20	–	–	﹤0.01%	274
2024 Q3	$3.12K	Buy	+20	New	+$3.23K	﹤0.01%	279

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hara Capital's AZN Position: Q2 2026 in Review

Hara Capital held its AstraZeneca (AZN) position steady in Q2 2026 at 20 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #271.

Hara Capital first reported a position in AZN in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.94K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Hara Capital held 20 shares of AstraZeneca worth $3.79K as of Q2 2026.
Hara Capital left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up ﹤0.01% of Hara Capital's portfolio in Q2 2026, its #271 holding.
Hara Capital first reported a position in AstraZeneca in Q3 2024 and has held it in 8 quarters since.
Hara Capital's AstraZeneca position peaked at $3.94K in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.